Source: PR Newswire

Press Release: Exosome Diagnostics : Bio-Techne's Exosome Diagnostics Laboratory Announces Reimbursement Contract With Humana

/PRNewswire/ -- Bio-Techne Corporation (NASDAQ:TECH) today announced that Humana has awarded a contract effective April 1, 2021 to its Exosome Diagnostics...

Read full article »
Exosome Diagnostics's Competitors | Exosome Diagnostics's News | Exosome Diagnostics's Financials
Stay up-to-date with the latest news on Exosome Diagnostics
Est. Annual Revenue
$5.0-25M
Est. Employees
100-250
CEO Avatar

CEO

Update CEO

CEO Approval Rating

- -/100

Read more
Stay up-to-date with the latest news on Exosome Diagnostics